Sign Up Today and Learn More About Oxford Science Enterprises Stock
Invest in or calculate the value of your shares in Oxford Science Enterprises or other pre-IPO companies through EquityZen, part of Morgan Stanley.
Oxford Science Enterprises Stock
Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.
About Oxford Science Enterprises Stock
Founded
2015
Industries
Software, Artificial Intelligence, Data and Analytics
Oxford Science Enterprises Press Mentions
Stay in the know about the latest news on Oxford Science Enterprises
Vivid Dx Raises $15 Million To Develop Rapid Blood-Based Infection Testing Platform
pulse2 • Jul 31, 2026
英国快速传染病检测技术开发商Vivid Dx获得1500万美元种子轮融资
ifastdata • Jul 31, 2026
Mirae Launches With $5.4M in Funding to Expand Access to World-Class Specialty Care
vcaonline • Jul 31, 2026
Mirae raises £4.1m led by Oxford Science Enterprises
startupmag • Jul 30, 2026
Vivid Dx Raises $15M in Seed Funding
finsmes • Jul 29, 2026
Oxford Science Enterprises Management
Leadership team at Oxford Science Enterprises
Senior investment associate
Sam Harman
Partner ( Life Sciences)
Claire Brown
Join now and verify your accreditation status to gain access to:
- Oxford Science Enterprises Current Valuation
- Oxford Science Enterprises Stock Price
- Oxford Science Enterprises Management
- Available deals in Oxford Science Enterprises and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Oxford Science Enterprises Cap Table and Funding History by Share Class and Liquidity Preferences
- Oxford Science Enterprises Revenue and Financials
- Oxford Science Enterprises Highlights
- Oxford Science Enterprises Business Model
- Oxford Science Enterprises Risk Factors
- Oxford Science Enterprises Research Report from SACRA Research
Trading Oxford Science Enterprises Stock
How to invest in Oxford Science Enterprises stock?
Accredited investors can buy pre-IPO stock in companies like Oxford Science Enterprises through EquityZen funds. These investments are made available by existing Oxford Science Enterprises shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Oxford Science Enterprises stock?
Shareholders can sell their Oxford Science Enterprises stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 56K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."